TNON Stock Analysis: Buy, Sell, or Hold?
TNON - Tenon Medical, Inc. Common Stock
$0.20
-0.01 (-4.84%)
▼
5d:
-17.07%
30d:
-67.19%
90d:
-75.06%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 12, 2026
27d
Get Alerted When TNON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TNON this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TNON is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TNON is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TNON is currently trading at $0.20, which is considered oversold relative to its 30-day fair value range of $0.28 to $0.60.
Technical Outlook: Technically, TNON is in a downtrend. The price is currently testing key support at $0.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.62 (+1183.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNON is in a downtrend. The price is currently testing key support at $0.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.62 (+1183.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.28 -
$0.60
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 1183.6% below Wall St target ($2.62)
- WARNING: Recommendation downgraded due to -17.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.28 -
$0.60
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.58
Resistance Level
$0.72
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.34
Wall Street Target
$2.63
(+1183.6%)
Revenue Growth (YoY)
89.9%
Profit Margin
-270.1%
Share & Embed Analysis
Last updated: July 14, 2026 10:21 PM ET
Data refreshes hourly during market hours. Next update: 11:21 PM
Data refreshes hourly during market hours. Next update: 11:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 50 HOLD |
